The Impact of Liver Cirrhosis on Outcomes in Trauma Patients

March 26, 2024 updated by: Methodist Health System
Given that there are only a few studies on the effects of cirrhosis on trauma patients and none have addressed the impact cirrhosis has on the incidence of infections, it is important that we study this to determine the mortality in cirrhotic trauma patients and ascertain the incidence of infectious complications in these patients. We hypothesize that trauma patients with cirrhosis will have higher rates of mortality and infectious complications.

Study Overview

Status

Completed

Conditions

Detailed Description

There have been a select few studies addressing the effects of cirrhosis on trauma patients. These studies show an increase in morbidity and mortality. However, there is limitation in the depth and breadth of analysis. The primary aim of this study is to determine the mortality rates in cirrhotic trauma patients with a secondary end-point being the determination of the incidence of infections associated with these patients.

Given that there are only a few studies on the effects of cirrhosis on trauma patients and none have addressed the impact cirrhosis has on the incidence of infections, it is important that we study this to determine the mortality in cirrhotic trauma patients and ascertain the incidence of infectious complications in these patients. PI hypothesizes that trauma patients with cirrhosis will have higher rates of mortality and infectious complications.

Study Type

Observational

Enrollment (Actual)

4774035

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Dallas, Texas, United States, 75203
        • Methodist Health System

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

Patients with confirmed diagnosis of cirrhosis via radiologic, laboratory profile and intraoperative findings will be selected.Data will be extracted from the NTDB & TQIP databanks from 2010-2018.

Description

Inclusion Criteria:

  • Cirrhotic trauma patients in the United States within 2010-2018
  • Patients ≥ 18 years old

Exclusion Criteria:

  • Patients less than 18 years old

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mortality
Time Frame: 2010-2018
Patient death
2010-2018
Incidence of infectious complications
Time Frame: 2010-2018
Incidents of complications with infections
2010-2018

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient demographics
Time Frame: 2010-2018
demographics of patients
2010-2018
vital signs; clinical measurements
Time Frame: 2010-2018
clinical measurements
2010-2018
vital signs; pulse rate
Time Frame: 2010-2018
pulse rate (bpm)
2010-2018
vital signs; temperature
Time Frame: 2010-2018
temperature
2010-2018
vital signs; respiration rate
Time Frame: 2010-2018
respiration rate
2010-2018
vital signs; blood pressure
Time Frame: 2010-2018
blood pressure
2010-2018
injury characteristics
Time Frame: 2010-2018
characteristics of injuries
2010-2018
hospital and ICU lengths of stay
Time Frame: 2010-2018
length of days patients stays in hospital/ICU
2010-2018
transfusion data
Time Frame: 2010-2018
data regarding transfusions
2010-2018
alcohol use indicator
Time Frame: 2010-2018
indicator of alcohol use
2010-2018
drug use indicator
Time Frame: 2010-2018
indicator of drug use
2010-2018
ventilator days
Time Frame: 2010-2018
days on ventilator
2010-2018
Abbreviated Injury Scale
Time Frame: 2010-2018
abbreviated injury scale score
2010-2018
Glasgow Coma Scale
Time Frame: 2010-2018
glasgow coma scale score
2010-2018
Injury Severity Score
Time Frame: 2010-2018
score of injury
2010-2018
discharge date
Time Frame: 2010-2018
date of discharge
2010-2018
arrival date
Time Frame: 2010-2018
date of arrival
2010-2018

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Parvez Mantry, MD, Methodist Dallas Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 16, 2018

Primary Completion (Actual)

September 4, 2020

Study Completion (Actual)

September 4, 2020

Study Registration Dates

First Submitted

August 12, 2019

First Submitted That Met QC Criteria

December 9, 2021

First Posted (Actual)

December 28, 2021

Study Record Updates

Last Update Posted (Actual)

March 27, 2024

Last Update Submitted That Met QC Criteria

March 26, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 042.HEP.2018.D

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cirrhosis

3
Subscribe